Certified Advisory Corp Biogen Inc. Transaction History

Certified Advisory Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $59,052 - $94,553	-228 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $36,964 - $41,459	-170 Reduced 42.71%	228 $53,000
Q1 2018 Apr 30, 2018	BUY	$260.13 - $367.91 $84,542 - $119,570	325 Added 445.21%	398 $108,000
Q4 2017 Feb 22, 2018	BUY	$307.64 - $344.58 $22,457 - $25,154	73	73 $23,000

1,035

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

Stay updated on Certified Advisory Corp with notifications on news.